콘텐츠 바로기

Ryoung Go-Kim 프로필
Ryoung Go-Kim 프로필
Ryoung Go-Kim 프로필
Hepatobiliary and Pancreatic Surgery
Ryoung Go-Kim Head of Department
Specialty
Laparoscopic and Robotic Surgery for Gallstones, Gallbladder Polyps, Gallbladder Cancer, Bile Duct Cancer, Pancreatic Cancer, Liver Cancer, and Splenic Diseases; Postoperative Chemotherapy; and End-of-Life Care for Terminal Patients
Month
06
  • Available
  • Fully Booked
Medical Schedule :

Please note that online reservations may not be available for some doctors depending on the department’s circumstances.

Appointment

Education & Experience

Education

  • Master's, Kangwon National University College of Medicine
  • Kangwon National University College of Medicine

Experience

  • 2016 - Present Director, Hepatobiliary&Pancreatic Surgery, Nuclear Hospital, Dongnam Institute of Radiological&Medical Sciences
  • 2023 - Present Head of Department, Surgery, Nuclear Hospital, Dongnam Institute of Radiological&Medical Sciences
  • 2024 - 2026 Head, Education&Training Team, Dongnam Institute of Radiological&Medical Sciences
  • 2013 - 2015 Fellow, Nuclear Hospital, Korea Institute of Radiological&Medical Sciences
  • 2008 - 2012 Resident, Nuclear Hospital, Korea Institute of Radiological&Medical Sciences
  • 2007 - 2008 Intern, Nuclear Hospital, Korea Institute of Radiological&Medical Sciences

Key Activities

  • Regular Member, Korean Society for Biochemistry and Molecular Biology
  • Lifetime Member, Korean Society of Surgical Oncology
  • Regular Member, Korean Study Group of Minimally Invasive Pancreatic Surgery
  • Regular Member, Korean Society of Endoscopic&Laparoscopic Surgeons
  • Lifetime Member, Korean Cancer Association
  • Lifetime Member, Korean Association of Hepato-Biliary-Pancreatic Surgery
  • Lifetime Member, Korean Surgical Society
  • Regular Member, Korean Medical Association

Awards

No awards registered.

Research & Publications

  • Ryounggo Kim, Sang Bum Kim, Eung-Ho Cho, Sun Hoo Park, Sung Bae Park, Seong Kweon Hong and Gibong Chae. CD44 expression in patients with combined hepatocellular cholangiocarcinoma. Ann Surg Treat Res 2015;89(1):9-16.
  • Seok Joon Lee, Eung-Ho Cho, Ryounggo Kim, Young Han Kim, Chang-Sup Lim and Sang Bum Kim. Hepatectomy, combined with intraoperative radiofrequency ablation in patients with multiple hepatocellular carcinoma. Korean J Hepatobiliary Pancreat Surg 2015 Aug;19(3):98-102
  • Choi JI, Cho EH, Kim SB, Kim R, Kwon J, Park M, Shin HJ, Ryu HS, Park SH, Lee KH. Promoter methylation of cysteine dioxygenase type 1: gene silencing and tumorigenesis in hepatocellular carcinoma. Ann Hepatobiliary Pancreat Surg. 2017;21:181-187. (Accepted August 11 2017)
  • Woohyung Lee, Ryounggo Kim, Soon-Chan Hong et al. Clinical implication of tumor site in terms of node metastasis for intrahepatic cholangiocarcinoma. European Journal of Surgical Oncology 46 (2020) 832-838. (Accepted 27. November 2019)
  • Kim R, Song J, Kim SB. Concurrent hepatocellular carcinoma metastasis to stomach, colon, and brain: A case report. World J Clin Cases 2020; 8(16): 3534-3541 (Accepted July 30.2020)